Lataa...
Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome
BACKGROUND: Ischemia-modified albumin (IMA) has been suggested as a marker of cardiac ischemia. Little, however, is known about its capacity to predict short-term serious cardiac outcomes (death, myocardial infarction, congestive heart failure, serious arrhythmia, or refractory ischemic cardiac pain...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Canadian Medical Association
2005
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1150260/ https://ncbi.nlm.nih.gov/pubmed/15967971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.045194 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|